Diethyl dithieno[3,2-b:2',3'-d]thiophene-2,6-dicarboxylate, 97.0%, 5g

H-D-Pro-Otbu, 95.0%, 5g

Azido-PEG7-amine>90.0%(HPLC)(T)250mg

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indoline-1-carboxylate, 95.0%, 5g

Ethyl 4-(2-aminoethyl)benzoate hydrochloride, 98%, 1g

(S)-Pyrrolidin-3-ylmethanol, 95.0%, 5g

4-Methylmorpholine>99.0%(GC)500mL

H-Cys(tBu)-OH.HCl, 98%, 10g

Ethyl7-chloro-2-methyl-thiazolo[5,4-b]pyridine-6-carboxylate, 98%, 10g

(3-Bromophenyl)triphenylsilane, 97%, 250mg

(5-Fluoro-pyrimidin-2-yl)-piperidin-4-yl-amine hydrochloride, 5g

Microliter syringe GASTIGHT® series 1700 Point type 3, 25 µl, 1702 RNR, 1 piece

Ethyl 1-methylpiperidine-2-carboxylate, 95.0%, 25g